NEO
Neogenomics, Inc.
A laboratory that focuses exclusively on cancer testing, helping oncologists and pathologists diagnose tumors and choose treatments through genetic and molecular analysis. Founded in 2001 in Fort Myers, Florida, by a pathologist and a healthcare executive, it has grown into one of the largest oncology-focused reference labs in the United States. The name blends "neo" — Greek for "new" — with "genomics," a nod to the modern genetic techniques at its core.
CUSIP: 64049M209HealthcareUS1 holder
Total Value
$676.6K
Total Shares
91.2K
Net Share Change
+91.2K
Activity
1 buying
Investor
Value
Shares
Weight
Change
